Terns Pharmaceuticals, Inc. (TERN)
52.65
-0.04
(-0.08%)
USD |
NASDAQ |
Apr 17, 16:00
52.62
-0.03
(-0.06%)
Pre-Market: 20:00
Terns Pharmaceuticals Cash from Investing (Quarterly) : -350.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -11.20B |
| Corcept Therapeutics, Inc. | -11.84M |
| Cogent Biosciences, Inc. | -322.77M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| ADMA Biologics, Inc. | -0.276M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.08M |
| Cash from Financing (Quarterly) | 743.12M |
| Free Cash Flow | -82.18M |
| Free Cash Flow Per Share (Quarterly) | -0.1939 |
| Free Cash Flow to Equity (Quarterly) | -18.97M |
| Free Cash Flow to Firm (Quarterly) | -19.08M |
| Free Cash Flow Yield | -1.67% |